Packaging and Labeling Compliance

The contract requires strict adherence to Defense Logistics Agency standards for pharmaceutical packaging and labeling, ensuring full traceability and regulatory compliance across all packaged medical products. Key labeling elements must include the CAGE code, National Drug Code, Contract Line Item Number, Requisition Date and Date of Delivery, and Document Identification Code, each accurately applied to meet federal procurement and inventory tracking mandates. The work falls under NAICS code 323113, indicating that the scope involves manufacturing products used in labeling and packaging for government distribution, with performance tied to DLA’s supply chain requirements. This subcontract is issued under the Department of Defense and is intended to support the Defense Logistics Agency’s logistical infrastructure for military and healthcare systems. The posting date of July 16, 2026, indicates it is a future-facing obligation, suggesting preparation and compliance activities must be underway prior to execution. While specific location details for performance or the point of contact are not provided, the contract references a specific solicitation and award identifier, underscoring its formal placement within DLA’s acquisition system and its binding nature for all parties involved. Noncompliance with labeling standards could result in rejection of shipments and disruption to authorized distribution channels.